- Home
- CDLR vs SLNO Comparison
CDLR vs SLNO Comparison
Compare CDLR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLR
- SLNO
- Stock Information
- Founded
- CDLR 2008
- SLNO 1999
- Country
- CDLR Denmark
- SLNO United States
- Employees
- CDLR N/A
- SLNO N/A
- Industry
- CDLR
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CDLR
- SLNO Health Care
- Exchange
- CDLR Nasdaq
- SLNO Nasdaq
- Market Cap
- CDLR 2.3B
- SLNO 1.9B
- IPO Year
- CDLR N/A
- SLNO 2014
- Fundamental
- Price
- CDLR $26.31
- SLNO $52.63
- Analyst Decision
- CDLR Strong Buy
- SLNO Strong Buy
- Analyst Count
- CDLR 1
- SLNO 7
- Target Price
- CDLR $37.00
- SLNO $67.14
- AVG Volume (30 Days)
- CDLR 37.0K
- SLNO 611.7K
- Earning Date
- CDLR 08-27-2024
- SLNO 11-05-2024
- Dividend Yield
- CDLR N/A
- SLNO N/A
- EPS Growth
- CDLR N/A
- SLNO N/A
- EPS
- CDLR N/A
- SLNO N/A
- Revenue
- CDLR $131,862,209.00
- SLNO N/A
- Revenue This Year
- CDLR $130.27
- SLNO N/A
- Revenue Next Year
- CDLR $105.38
- SLNO N/A
- P/E Ratio
- CDLR N/A
- SLNO N/A
- Revenue Growth
- CDLR N/A
- SLNO N/A
- 52 Week Low
- CDLR $16.29
- SLNO $3.96
- 52 Week High
- CDLR $27.32
- SLNO $54.09
- Technical
- Relative Strength Index (RSI)
- CDLR 56.04
- SLNO 60.12
- Support Level
- CDLR $24.48
- SLNO $48.38
- Resistance Level
- CDLR $26.66
- SLNO $54.09
- Average True Range (ATR)
- CDLR 0.42
- SLNO 2.49
- MACD
- CDLR 0.03
- SLNO 0.35
- Stochastic Oscillator
- CDLR 85.97
- SLNO 82.47
About CDLR Cadeler AS
Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning, and provides marine and engineering operations to the wind industry with a focus on safety and the environment. The company operates four offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.